Virus News and Research

Latest Virus News and Research

Gene therapy helps alcoholic rats

As a follow up to previous work showing that gene therapy can reduce drinking in rats trained to prefer alcohol, scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have used the same technique to cut drinking in rats with a genetic predisposition for heavy alcohol consumption.

5 May 2004

Virginia prepares for mosquito borne diseases

The Virginia Department of Health reminds residents that mosquito season has arrived, and with it the risk of mosquito-transmitted viral diseases that can cause brain inflammation/encephalitis in humans.

4 May 2004

New license agreement for rotavirus diarrhea vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today a new license agreement aimed at helping to prevent hundreds of thousands of deaths annually from rotavirus diarrhea in children living in developing countries.

4 May 2004

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

Pharmaceutical science leaders from the FDA, research institutions and top pharmaceutical companies will gather at the 2004 AAPS National Biotechnology Conference, AAPS' spring annual meeting.

4 May 2004

Computers to combat disease

A new initiative harnesses the USA's computing skill to enhance our ability to respond to disease epidemics and bioterrorism.

4 May 2004

New technique to deliver gene therapy to soft-tissue tumors

Using new research and technology that shows bone marrow-derived mesenchymal stem cells (MSCs) will engraft at the site of a tumor and contribute to the growth of stromal fibroblasts (the healthy tissue surrounding a tumor)

2 May 2004

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

MedImmune, Inc. has announced clinical data showing that a live, attenuated intranasal influenza vaccine (LAIV) may help induce broader immunity in children against drifted influenza strains when compared to the traditional flu shot (TIV).

2 May 2004

Once expected to die in early childhood, children born with HIV are now surviving into their teens

Once expected to die in early childhood, children born with HIV are now surviving into their teens and early adulthood thanks to research advances over the past decade. However, it's also likely these children will develop drug resistance due to sequential exposure to HIV treatments, including antiretroviral (ARV) therapies.

2 May 2004

Zoonoses, diseases transmitted from animals to humans

The World Health Organization (WHO) is hosting a three-day consultation to identify the factors that allow diseases to jump from animals to humans (zoonoses), as well as to improve surveillance systems for their monitoring and control.

1 May 2004

Health Canada urges Canadians to protect against West Nile Virus

Health Canada and its partners are reminding Canadians to take active steps to protect themselves from the risk of West Nile Virus.

29 Apr 2004

Chinese authorities announce 9th suspected SARS case

Chinese health authorities have announced that an additional case of SARS is under investigation. This brings the total number of cases in China, reported since 22 April, to nine. Of these, one has died.

29 Apr 2004

Pennsylvania launches West Nile virus surveillance program

Officials from the state departments of Agriculture, Environmental Protection and Health today joined representatives from Cumberland and Dauphin counties to launch Pennsylvania’s program to detect and control mosquitoes that carry West Nile virus.

28 Apr 2004

Two outbreaks in humans of deadly Nipah virus in reported Bangladesh

Wildlife Trust's Consortium for Conservation Medicine reports that the World Health Organization (WHO) has now confirmed two recent outbreaks in humans of deadly Nipah virus in Bangladesh. The Consortium has been researching the origins of Nipah virus under a grant from the National Institutes of Health.

28 Apr 2004

HIV drug market will grow to an $8 billion industry by 2013

Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, forecasts that the HIV drug market will grow to more than $8 billion by 2013.

28 Apr 2004

Hong Kong officials review laboratory safety procedures

In view of current events on mainland China, The Centre for Health Protection's, Dr P Y Leung, today (April 27) called a meeting with representatives of the Department of Health (DH), Hospital Authority and universities to review laboratory safety procedures in Hong Kong.

28 Apr 2004

Tips to avoid Lyme disease and West Nile virus

What's bugging you now that spring is here? Probably the same thing that's bugging your child -– mosquitoes, ticks and other flying, crawling, or creeping creatures of the great outdoors. Not only are these bugs' bites and stings painful and itchy, the potential health risk of insect-borne diseases -- such as Lyme disease and West Nile virus

28 Apr 2004

Experimental smallpox DNA vaccine

In the first successful study of its kind, scientists have shown that a DNA-based vaccine for smallpox can protect nonhuman primates from monkeypox, a disease that resembles smallpox in humans.

27 Apr 2004

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

Medical Services International Inc. has announced that it has been requested to ship VScan Dengue Fever test kits to Hong Kong immediately.

27 Apr 2004

Experimental immune-boosting drug interleukin-2 helps HIV Patients

National Institutes of Health (NIH) scientists report that brief, widely-spaced courses of the experimental immune-boosting drug interleukin-2 (IL-2) allow people with HIV to maintain near normal levels of a key immune system cell for long periods.

26 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004